
Moderna, Inc. Hits New 52-Week Low at USD 23.04 Amid Declining Sales
2025-11-10 17:23:21Moderna, Inc. has reached a new 52-week low, reflecting a challenging year marked by an 83.48% decline in stock price. The company reported significant losses, with net sales dropping 82.12% and a net profit loss of nearly $2.9 billion, compounded by rising raw material costs.
Read MoreIs Moderna, Inc. technically bullish or bearish?
2025-11-05 11:22:32As of 31 October 2025, the technical trend for Moderna, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows a bullish signal on the monthly but no signal on the weekly. However, the Bollinger Bands, KST, and moving averages indicate bearish trends, particularly on the daily and weekly time frames. Dow Theory shows no trend in both weekly and monthly evaluations. In terms of performance, Moderna has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -42.88% compared to the S&P 500's 16.30%, and a one-year return of -56.53% versus 19.89% for the index....
Read More
Moderna Stock Hits Day Low at $24.74 Amid Price Pressure
2025-11-04 18:33:15Moderna, Inc. has faced significant stock volatility, with notable declines over various timeframes, including a year-to-date drop of 40.09%. The company reported a substantial decrease in net sales and a considerable net profit loss, compounded by rising raw material costs, indicating ongoing financial challenges.
Read More
Moderna, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
2025-11-04 16:12:46Moderna, Inc. has recently revised its evaluation amid challenging market conditions, with its stock price declining significantly over the past year. The company has faced substantial losses compared to the S&P 500, and technical indicators present mixed signals, reflecting ongoing volatility and a cautious outlook for its performance.
Read MoreIs Moderna, Inc. technically bullish or bearish?
2025-11-04 11:33:57As of 31 October 2025, the technical trend for Moderna, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a bearish trend and the weekly KST and Dow Theory also showing bearish signals. While the MACD is mildly bullish on both weekly and monthly time frames, the overall indicators suggest weakness. The RSI is bullish on a monthly basis but shows no signal weekly, indicating mixed momentum. Additionally, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -40.09% compared to the S&P 500's 16.30%....
Read MoreIs Moderna, Inc. technically bullish or bearish?
2025-11-03 11:33:46As of 31 October 2025, the technical trend for Moderna, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages and the weekly KST and Dow Theory indicators, both of which are bearish. The MACD shows a mildly bullish signal on the weekly and monthly time frames, while the RSI indicates a bullish condition on the monthly but no signal on the weekly. Overall, the mixed signals suggest a lack of strong momentum in either direction. In terms of performance, Moderna has underperformed significantly compared to the S&P 500 across multiple periods, with a year-to-date return of -34.68% versus the S&P 500's 16.30%, and a one-year return of -50.04% compared to the S&P 500's 19.89%....
Read MoreIs Moderna, Inc. technically bullish or bearish?
2025-11-02 11:18:20As of 31 October 2025, the technical trend for Moderna, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend and weekly KST and Dow Theory both showing bearish signals. However, the MACD on both weekly and monthly timeframes is mildly bullish, and the monthly RSI is bullish, suggesting some underlying strength. Despite this, the overall technical indicators lean towards a bearish outlook. Over the past year, Moderna has significantly underperformed the S&P 500, with a return of -50.04% compared to the S&P's 19.89%....
Read More
Moderna Stock Soars 13.93%, Hits Intraday High of $29.20
2025-10-31 17:04:22Moderna, Inc. has seen notable stock activity today, contrasting with a flat S&P 500. Despite recent gains, the company faces significant challenges, including a sharp decline in net sales and profit losses. Additionally, raw material costs have surged, highlighting ongoing financial difficulties within the biotechnology sector.
Read More
Moderna, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
2025-09-22 18:20:05Moderna, Inc. has recently revised its evaluation amid ongoing market challenges, with its stock priced at $25.24. Over the past year, the company has experienced a significant decline, contrasting sharply with the S&P 500's performance. Technical indicators show mixed signals, reflecting underlying selling pressure.
Read More





